Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyCol in mild to moderate ulcerative colitis
NCT01033305Phase 2Completed
- Sponsor
- Sigmoid Pharma
- Start
- Mar 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Cycol in ulcerative colitis (UC), sponsored by Sigmoid Pharma. Started Mar 2010; status: completed.
02
Drugs
Cycol
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01033305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033305.